RefleXion Medical announced today that it signed a licensing agreement with Limbus AI to incorporate software into radiation treatment planning. The agreement enables the integration of the Limbus Contour automated contour software into the RefleXion X1 system. X1 uses biology-guided radiotherapy (BgRT) technology. It enables a PET radiotracer to create a unified motion management solution […]
RefleXion Medical
First cancer patient treated with RefleXion biology-guided radiotherapy
RefleXion Medical announced today that the first patient completed treatment with Scintix biology-guided radiotherapy on its X1 machine. Scintix treats early- and late-stage cancers using the individual biology of each tumor to drive its own treatment. It allows each cancer’s unique biology to autonomously determine how much radiation to deliver. This occurs on a second-by-second […]
FDA clears biology-guided radiotherapy from RefleXion
RefleXion Medical announced today that the FDA cleared its Scintix biology-guided radiotherapy treatment for cancer. Hayward, California-based RefleXion designed the Scintix platform for use in treating both early- and late-stage cancers. The company said Scintix is the first and only radiotherapy that allows each cancer’s unique biology to autonomously determine how much radiation to deliver. […]
RefleXion expands footprint through multi-system contract with Select Healthcare
RefleXion Medical announced today that it entered into a three-system contract with Select Healthcare cancer facility developer. The multi-year, multi-site contract was agreed upon with the aim of creating new, free-standing treatment centers using the RefleXion X1 platform for treating all stages of cancer with external beam radiotherapy (EBRT). RefleXion said in a news release […]
RefleXion, Mirada ink licensing deal on personalized cancer treatment
RefleXion Medical announced today that it entered into a non-exclusive, worldwide licensing agreement with Mirada Medical. The agreement allows for the integration of Mirada’s RegEngine image registration algorithms into the RefleXion X1 treatment planning software, aligning patient anatomy between different imaging modalities or between radiotherapy treatments. “Day-of-treatment modifications, called adaptive radiotherapy, are critical for responding […]
RefleXion closes $125M debt facility
Biology-guided radiotherapy (BgRT) technology developer RefleXion Medical announced today that it closed a $125 million debt facility. Hayward, California–based RefleXion has $55 million of the $125 million total available immediately to repay its existing $50 million in debt. The remaining $70 million will be made available upon the achievement of certain regulatory and commercial milestones. […]
RefleXion raises $80M for biology-guided radiotherapy tech
RefleXion Medical announced that it closed an $80 million equity financing to support its therapeutic oncology technology. Hayward, California-based RefleXion develops biology-guided radiotherapy (BgRT) for all stages of cancer. The company designed BgRT to transform an injected radiotracer into a unified motion management solution that overcomes the technical limitations currently restricting radiotherapy use to one […]
RefleXion, Merck team up on late-stage cancer study
RefleXion announced today that it entered into a clinical collaboration with Merck to evaluate Merck’s (NYSE:MRK) Keytruda anti-PD-1 therapy in clinical trials. Hayward, Calif.-based therapeutic oncology company RefleXion is joining forces with Merck to evaluate Keytruda’s safety and efficacy in combination with RefleXion’s biology-guided radiotherapy (BgRT) in multiple late-stage cancers, including non-small cell lung cancer, in […]
RefleXion Medical raises $100m for biology-guided cancer radiotherapy
Therapeutic oncology company RefleXion Medical announced today that it closed an equity financing with proceeds of $100 million. Public Sector Pension Investment Board (PSP Investments), a large, Canada-based pension investment manager focused on long-term investments, led the funding, according to a news release. Existing investors TPG’s The Rise Fund, KCK Group, Sofinnova Partners, Venrock, T. […]
Medtech companies raised more than $738 million in Q2
Venture capital firms invested more than $738 million during the second quarter of 2018, $1 million less than the first quarter of this year, according to the MoneyTree Report from PricewaterhouseCoopers (PwC) and CB Insights. There was a total of 61 deals during Q2, an increase from the 48 that the industry saw during Q1. […]
